Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Report 2026
Download Free Sample Buy Now
Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Global Report 2026 Market Report Infographic Image
Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Report 2026

Global Outlook – By Product (Gene Therapy, Cell Therapy, Tissue Engineered), By Phase (Phase I, Phase II, Phase III, Phase IV), By Indication (Oncology, Cardiology, Central Nervous System And Musculoskeletal, Infectious Disease, Dermatology, Endocrine, Metabolic, Genetic, Immunology And Inflammation, Ophthalmology, Hematology) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Overview

• Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) market size has reached to $6.2 billion in 2025

• Expected to grow to $12.55 billion in 2030 at a compound annual growth rate (CAGR) of 14.8%

• Growth Driver: Rising Clinical Trial Numbers Fuel Growth In The ATMP CDMO Market

• Market Trend: Transforming Cell Therapy Manufacturing With Innovations In Advanced Therapy Medicinal Products

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market?

An advanced therapy medicinal product contract development and manufacturing organization (CDMO) is a specialized service provider that assists in the development and manufacturing of advanced therapy medicinal products. The objective of an advanced therapy medicinal product CDMO is to provide the expertise, infrastructure, and resources required for advanced therapy medicinal product development and manufacturing.

The main types of products of advanced therapy medicinal products contract development and manufacturing organization (CDMO) include gene therapy, cell therapy, and tissue engineered. Gene therapy involves the introduction, removal, or alteration of genetic material within a patient's cells to treat or prevent disease. This can be done using viral or non-viral vectors to deliver therapeutic genes to target cells in several phases, such as phase I, phase II, phase III, and phase IV for the treatment of various indications, including oncology, cardiology, central nervous system and musculoskeletal, infectious disease, dermatology, endocrine, metabolic, genetic, immunology and inflammation, ophthalmology, and hematology.

Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Global Report 2026 Market Report bar graph

What Is The Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Size and Share 2026?

The advanced therapy medicinal products contract development and manufacturing organization (cdmo) market size has grown rapidly in recent years. It will grow from $6.2 billion in 2025 to $7.24 billion in 2026 at a compound annual growth rate (CAGR) of 16.7%. The growth in the historic period can be attributed to limited availability of specialized cdmo services, increasing r&d investment in advanced therapies, early adoption of gene and cell therapies, rising prevalence of complex diseases, growth of small biotech startups.

What Is The Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Growth Forecast?

The advanced therapy medicinal products contract development and manufacturing organization (cdmo) market size is expected to see rapid growth in the next few years. It will grow to $12.55 billion in 2030 at a compound annual growth rate (CAGR) of 14.8%. The growth in the forecast period can be attributed to advancements in scalable manufacturing technologies, increasing collaborations between cdmos and pharma, growth of autologous and allogeneic therapies, rising global demand for personalized medicine, expansion into emerging markets. Major trends in the forecast period include rising demand for cdmo services in advanced therapy development, expansion of gene, cell, and tissue engineered therapies, increasing focus on regulatory compliance and quality standards, growth in outsourced manufacturing for biopharmaceutical companies, adoption of scalable and flexible manufacturing platforms.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Segmentation

1) By Product: Gene Therapy, Cell Therapy, Tissue Engineered

2) By Phase: Phase I, Phase II, Phase III, Phase IV

3) By Indication: Oncology, Cardiology, Central Nervous System And Musculoskeletal, Infectious Disease, Dermatology, Endocrine, Metabolic, Genetic, Immunology And Inflammation, Ophthalmology, Hematology

Subsegments:

1) By Gene Therapy: Viral Vectors, Non-Viral Vectors, Dna Or Rna-Based Products

2) By Cell Therapy: Autologous Cell Therapy, Allogeneic Cell Therapy, Stem Cell Therapy

3) By Tissue Engineered: Skin Substitutes, Cartilage And Bone Tissue, Vascular Grafts And Organs

What Is The Driver Of The Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market?

The increasing number of clinical trials is expected to propel the growth of the advanced therapy medicinal products CDMO market going forward. Clinical trials are research studies conducted in humans to evaluate the safety and efficacy of medical interventions such as drugs, treatments, devices, or preventive measures. Clinical trial numbers are rising to meet the increasing demand for innovative treatments and to address a growing global disease burden. With the use of advanced therapy medicinal products, the demand for CDMO manufacturing services rises, leveraging specialized expertise and infrastructure. Clinical trial data aids in optimizing manufacturing, ensuring scalability, and quality maintenance to meet larger clinical and commercial needs. For instance, in July 2024, according to the Royal Pharmaceutical Society, a UK-based professional membership body, the number of people recruited to clinical trials in the UK in 2023/2024 was 349,019, an increase from 342,390 people in 2022/2023. Therefore, the increasing number of clinical trials is driving the growth of the advanced therapy medicinal products CDMO market.

Key Players In The Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

Major companies operating in the advanced therapy medicinal products contract development and manufacturing organization (cdmo) market are Thermo Fisher Scientific Inc., Merck KGaA, Lonza Group AG, Catalent Inc., Charles River Laboratories International Inc., Recipharm AB, KBI Biopharma, Takara Bio Inc., Rentschler Biopharma SE, Ajinomoto Co. Inc., ElevateBio LLC, Fujifilm Diosynth Biotechnologies, Axplora Group GmbH, WuXi Advanced Therapies Inc., Celonic Group, Batavia Biosciences B.V., BioCentriq, Cytovance Biologics, Andelyn Biosciences, Genezen, AGC Biologics, ABL Manufacturing, Minaris Regenerative Medicine, Porton Advanced Solutions

Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Trends and Insights

Major companies operating in the advanced therapy medicinal products CDMO market are developing advanced cell therapy manufacturing services to overcome critical issues in cell therapy manufacturing and speed the development activities of their partners. Cell therapy manufacturing services are contract development and manufacturing organization services that offer services which vary from early preclinical development to late-stage clinical trials and commercialization. For instance, in January 2024, Pluristem Therapeutics Inc., an Israel-based biotech company that transforms cells into solutions, launched PluriCDMO, a new business division offering cell therapy manufacturing. It utilizes a patented bioreactor system that allows for 3D cell multiplication, facilitating the production of a variety of cell types such as stem cells, induced pluripotent stem cells, exosomes, and immune therapies. PluriCDMO desires to provide high-quality, vital medicines to patients while maintaining unique batch-to-batch consistency in a scalable and cost-effective manner in good manufacturing practice settings.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market?

In January 2025, Altaris, LLC, a US-based investment firm focused on healthcare and building companies in the medical-product and biotech services space, acquired Minaris Regenerative Medicine from Resonac Corporation for an undisclosed amount. Through this acquisition, Altaris aims to deepen its footprint in the advanced therapy medicinal products (ATMP) contract development and manufacturing (CDMO) sector and accelerate its strategy to scale life-changing cell and gene therapies globally. Minaris Regenerative Medicine is a US-based CDMO providing autologous and allogeneic cell therapy manufacturing services across clinical and commercial stages.

Regional Outlook

North America was the largest region in the advanced therapy medicinal product contract development and manufacturing organization (CDMO) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market?

The advanced therapy medicinal product contract development and manufacturing organization (CDMO) market includes revenues earned by entities by providing services such as process development, analytical method development, good manufacturing practice manufacturing, and quality control testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The advanced therapy medicinal products CDMO market also includes sales of bioreactors and fermenters, cryopreservation equipment, and laboratory instruments. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Report 2026?

The advanced therapy medicinal products contract development and manufacturing organization (cdmo) market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the advanced therapy medicinal products contract development and manufacturing organization (cdmo) industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $7.24 billion
Revenue Forecast In 2035 $12.55 billion
Growth Rate CAGR of 16.7% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Product, Phase, Indication
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Thermo Fisher Scientific Inc., Merck KGaA, Lonza Group AG, Catalent Inc., Charles River Laboratories International Inc., Recipharm AB, KBI Biopharma, Takara Bio Inc., Rentschler Biopharma SE, Ajinomoto Co. Inc., ElevateBio LLC, Fujifilm Diosynth Biotechnologies, Axplora Group GmbH, WuXi Advanced Therapies Inc., Celonic Group, Batavia Biosciences B.V., BioCentriq, Cytovance Biologics, Andelyn Biosciences, Genezen, AGC Biologics, ABL Manufacturing, Minaris Regenerative Medicine, Porton Advanced Solutions
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Industry 4.0 & Intelligent Manufacturing

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Artificial Intelligence & Autonomous Intelligence

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Rising Demand For Cdmo Services In Advanced Therapy Development

4.2.2 Expansion Of Gene, Cell, And Tissue Engineered Therapies

4.2.3 Increasing Focus On Regulatory Compliance And Quality Standards

4.2.4 Growth In Outsourced Manufacturing For Biopharmaceutical Companies

4.2.5 Adoption Of Scalable And Flexible Manufacturing Platforms

5. Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Analysis Of End Use Industries

5.1 Pharmaceutical Companies

5.2 Biotechnology Companies

5.3 Academic And Research Institutions

5.4 Hospitals And Clinics

5.5 Contract Research Organizations

6. Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Size, Comparisons And Growth Rate Analysis

7.3. Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Segmentation

9.1. Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Gene Therapy, Cell Therapy, Tissue Engineered

9.2. Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Phase I, Phase II, Phase III, Phase IV

9.3. Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oncology, Cardiology, Central Nervous System And Musculoskeletal, Infectious Disease, Dermatology, Endocrine, Metabolic, Genetic, Immunology And Inflammation, Ophthalmology, Hematology

9.4. Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Gene Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Viral Vectors, Non-Viral Vectors, Dna Or Rna-Based Products

9.5. Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Cell Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Autologous Cell Therapy, Allogeneic Cell Therapy, Stem Cell Therapy

9.6. Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Tissue Engineered, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Skin Substitutes, Cartilage And Bone Tissue, Vascular Grafts And Organs

10. Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Regional And Country Analysis

10.1. Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

11.1. Asia-Pacific Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Segmentation By Phase, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

12.1. China Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Segmentation By Phase, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

13.1. India Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Segmentation By Phase, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

14.1. Japan Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Segmentation By Phase, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

15.1. Australia Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Segmentation By Phase, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

16.1. Indonesia Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Segmentation By Phase, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

17.1. South Korea Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Segmentation By Phase, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

18.1. Taiwan Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Segmentation By Phase, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

19.1. South East Asia Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Segmentation By Phase, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

20.1. Western Europe Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Segmentation By Phase, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

21.1. UK Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Segmentation By Phase, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

22.1. Germany Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Segmentation By Phase, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

23.1. France Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Segmentation By Phase, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

24.1. Italy Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Segmentation By Phase, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

25.1. Spain Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Segmentation By Phase, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

26.1. Eastern Europe Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Segmentation By Phase, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

27.1. Russia Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Segmentation By Phase, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

28.1. North America Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Segmentation By Phase, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

29.1. USA Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Segmentation By Phase, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

30.1. Canada Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Segmentation By Phase, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

31.1. South America Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Segmentation By Phase, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

32.1. Brazil Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Segmentation By Phase, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

33.1. Middle East Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Segmentation By Phase, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

34.1. Africa Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Segmentation By Phase, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Regulatory and Investment Landscape

36. Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Competitive Landscape And Company Profiles

36.1. Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Company Profiles

36.3.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Catalent Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Charles River Laboratories International Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Other Major And Innovative Companies

Recipharm AB, KBI Biopharma, Takara Bio Inc., Rentschler Biopharma SE, Ajinomoto Co. Inc., ElevateBio LLC, Fujifilm Diosynth Biotechnologies, Axplora Group GmbH, WuXi Advanced Therapies Inc., Celonic Group, Batavia Biosciences B.V., BioCentriq, Cytovance Biologics, Andelyn Biosciences, Genezen

38. Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market

40. Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market High Potential Countries, Segments and Strategies

40.1 Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market In 2030 - Countries Offering Most New Opportunities

40.2 Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market In 2030 - Segments Offering Most New Opportunities

40.3 Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Overview Of Key Products - Product Examples
  • Table 2: Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Supply Chain Analysis
  • Table 4: Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Major Raw Material Providers
  • Table 5: Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Major Resource Providers
  • Table 6: Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Major Manufacturers (Suppliers)
  • Table 7: Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Major Distributors And Channel Partners
  • Table 8: Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Key Technologies & Future Trends
  • Table 9: Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Major Trends
  • Table 10: Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Major End Users
  • Table 11: Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market - TAM, US$ Billion, 2025
  • Table 15: Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Gene Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Cell Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Tissue Engineered, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Asia-Pacific, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: China, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: India, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Japan, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Australia, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Indonesia, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: South Korea, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Taiwan, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South East Asia , Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia , Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia , Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Western Europe, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: UK, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Germany, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: France, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Italy, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Spain, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Eastern Europe, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Russia, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: North America, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: USA, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: Canada, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: South America, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Brazil, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Middle East, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Africa, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 96: Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market - Company Scoring Matrix
  • Table 97: Thermo Fisher Scientific Inc. Financial Performance
  • Table 98: Merck KGaA Financial Performance
  • Table 99: Lonza Group AG Financial Performance
  • Table 100: Catalent Inc. Financial Performance
  • Table 101: Charles River Laboratories International Inc. Financial Performance
  • Table 102: Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Competitive Benchmarking (In USD Billions)
  • Table 103: Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Competitive Dashboard
  • Table 104: Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 105: Global, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Size Gain ($ Billion), Segmentation By Product, 2025 – 2030
  • Table 106: Global, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Size Gain ($ Billion), Segmentation By Phase, 2025 – 2030
  • Table 107: Global, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030

List Of Figures

    Figure 1: Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Supply Chain Analysis
  • Figure 4: Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Major Raw Material Providers
  • Figure 5: Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Major Resource Providers
  • Figure 6: Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Major Distributors And Channel Partners
  • Figure 8: Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Key Technologies & Future Trends
  • Figure 9: Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Major Trends
  • Figure 10: Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Major End Users
  • Figure 11: Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market - TAM, US$ Billion, 2025
  • Figure 15: Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Gene Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Cell Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Tissue Engineered, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Asia-Pacific, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: China, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: India, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Japan, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Australia, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Indonesia, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: South Korea, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Taiwan, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South East Asia , Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia , Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia , Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Western Europe, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: UK, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Germany, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: France, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Italy, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Spain, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Eastern Europe, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Russia, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: North America, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: USA, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: Canada, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: South America, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Brazil, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Middle East, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Africa, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 96: Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market - Company Scoring Matrix
  • Figure 97: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 98: Merck KGaA Financial Performance
  • Figure 99: Lonza Group AG Financial Performance
  • Figure 100: Catalent Inc. Financial Performance
  • Figure 101: Charles River Laboratories International Inc. Financial Performance
  • Figure 102: Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Competitive Benchmarking (In USD Billions)
  • Figure 103: Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, Competitive Dashboard
  • Figure 104: Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 105: Global, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Size Gain ($ Billion), Segmentation By Product, 2025 – 2030
  • Figure 106: Global, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Size Gain ($ Billion), Segmentation By Phase, 2025 – 2030
  • Figure 107: Global, Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

Read More About Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Read More About Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Read More About Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Explore the latest trends, growth insights, and forecasts in the Key Trend Shaping The Ophthalmology Medical Service Market.

Read More About Explore the latest trends, growth insights, and forecasts in the Key Trend Shaping The Ophthalmology Medical Service Market.

Explore the latest trends, growth insights, and forecasts in the Nutrition Analysis Software Global Market.

Read More About Explore the latest trends, growth insights, and forecasts in the Nutrition Analysis Software Global Market.

Explore the latest trends, growth insights, and forecasts in the Global Wearable Fitness Trackers Market.

Read More About Explore the latest trends, growth insights, and forecasts in the Global Wearable Fitness Trackers Market.

Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Report 2026 - Global Outlook – By Product (Gene Therapy, Cell Therapy, Tissue Engineered), By Phase (Phase I, Phase II...

Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Report 2026 - Global Outlook – By Product Type (Semi-Solid Formulations, Liquid Formulations Drugs, Solid Formulations, Transdermal Products...

Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Report 2026 - Global Outlook – By Type (Contract Manufacturing Services, Contract Research Services), By Research Phase (Preclinical, Phase ...

Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Report 2026 - Global Outlook – By Product Type (Gene Therapy, Gene-Modified Cell Therapy, Cell Therapy), By Phase (Phase 1, Phase 2,...

Pharmaceutical Contract Packaging Market Report 2026 - Global Outlook – By Product (Primary Packaging, Secondary Packaging, Tertiary Packaging ), By Material (Paper And Paperboard, Plastics And Polymers, Aluminum Foil, G...

Advanced Therapeutics Pharmaceutical Outsourcing Market Report 2026 - Global Outlook – By Service Type (Contract Research Organizations (CROs), Contract Development And Manufacturing Organizations (CDMOs)), By Indication...

Drug Formulation Market Report 2026 - Global Outlook – By Dosage Form (Oral formulations, Parenteral Formulations, Topical Formulations, Inhalation Formulations), By Formulation (Tablets, Capsules, Injectable, Sprays, Su...

Biopharmaceuticals Contract Manufacturing Market Report 2026 - Global Outlook – By Product (Biologics, Monoclonal Antibodies (MABs), Recombinant Proteins, Vaccines, Antisense, RNAI, And Molecular Therapy, Biosimilars), B...

Frequently Asked Questions

The Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) market was valued at $6.2 billion in 2025, increased to $7.24 billion in 2026, and is projected to reach $12.55 billion by 2030. request a sample here

The global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) market is expected to grow at a CAGR of 14.8% from 2026 to 2035 to reach $12.55 billion by 2035. request a sample here

Some Key Players in the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) market Include, Thermo Fisher Scientific Inc., Merck KGaA, Lonza Group AG, Catalent Inc., Charles River Laboratories International Inc., Recipharm AB, KBI Biopharma, Takara Bio Inc., Rentschler Biopharma SE, Ajinomoto Co. Inc., ElevateBio LLC, Fujifilm Diosynth Biotechnologies, Axplora Group GmbH, WuXi Advanced Therapies Inc., Celonic Group, Batavia Biosciences B.V., BioCentriq, Cytovance Biologics, Andelyn Biosciences, Genezen, AGC Biologics, ABL Manufacturing, Minaris Regenerative Medicine, Porton Advanced Solutions . request a sample here

Major trend in this market includes: Transforming Cell Therapy Manufacturing With Innovations In Advanced Therapy Medicinal Products. For further insights on this market. request a sample here

North America was the largest region in the advanced therapy medicinal product contract development and manufacturing organization (CDMO) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the advanced therapy medicinal products contract development and manufacturing organization (cdmo) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Major companies operating in the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Report 2026 market are Major companies operating in the advanced therapy medicinal products contract development and manufacturing organization (cdmo) market are Thermo Fisher Scientific Inc., Merck KGaA, Lonza Group AG, Catalent Inc., Charles River Laboratories International Inc., Recipharm AB, KBI Biopharma, Takara Bio Inc., Rentschler Biopharma SE, Ajinomoto Co. Inc., ElevateBio LLC, Fujifilm Diosynth Biotechnologies, Axplora Group GmbH, WuXi Advanced Therapies Inc., Celonic Group, Batavia Biosciences B.V., BioCentriq, Cytovance Biologics, Andelyn Biosciences, Genezen, AGC Biologics, ABL Manufacturing, Minaris Regenerative Medicine, Porton Advanced Solutions request a sample here.

North America was the largest region in the advanced therapy medicinal product contract development and manufacturing organization (CDMO) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the advanced therapy medicinal products contract development and manufacturing organization (cdmo) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us